Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial To Assess The Prevention Of Lymphedema In ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2014-2017

ABSTRACT

This is a pilot study at the National Cancer Institute (INT) of Milan evaluated the feasibility of selective axillary dissection (SAD) which preserved the lymphatic drainage of the arm. Lymph nodes draining the arm are identified following radiotracer injection and lymphoscintigraphy, a technique called axillary reverse mapping (ARM). SAD was found feasible in 75% of patients. Furthermore only 9% had BCRL after SAD compared to 33% after axillary lymph node dissection (ALND). Detailed Description To evaluate the efficacy, safety and cost reduction of SAD compared to standard ALND, we propose a prospective 2-arm randomised trial. The control arm consists of patients randomized to ALND, the study arm consists of patients randomized to SAD. More... »

URL

https://clinicaltrials.gov/show/NCT03083314

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This is a pilot study at the National Cancer Institute (INT) of Milan evaluated the feasibility of selective axillary dissection (SAD) which preserved the lymphatic drainage of the arm. Lymph nodes draining the arm are identified following radiotracer injection and lymphoscintigraphy, a technique called axillary reverse mapping (ARM). SAD was found feasible in 75% of patients. Furthermore only 9% had BCRL after SAD compared to 33% after axillary lymph node dissection (ALND).\n\nDetailed Description\nTo evaluate the efficacy, safety and cost reduction of SAD compared to standard ALND, we propose a prospective 2-arm randomised trial. The control arm consists of patients randomized to ALND, the study arm consists of patients randomized to SAD.", 
    "endDate": "2017-06-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03083314", 
    "keywords": [
      "axillary lymph node", 
      "randomised clinical trial", 
      "breast cancer treatment", 
      "National Cancer Institute", 
      "int", 
      "Milan", 
      "feasibility", 
      "axillary dissection", 
      "lymphatic drainage", 
      "arm", 
      "lymph node", 
      "radiotracers", 
      "mapping", 
      "patient", 
      "efficacy", 
      "safety", 
      "cost reduction", 
      "control arm", 
      "study arm"
    ], 
    "name": "SELECTIVE AXILLARY LYMPH NODE DISSECTION VS COMPLETE AXILLARY DISSECTION: A RANDOMISED CLINICAL TRIAL TO ASSESS THE PREVENTION OF LYMPHEDEMA IN BREAST CANCER TREATMENT", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03083314"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00023.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.417893.0", 
        "type": "Organization"
      }
    ], 
    "startDate": "2014-06-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1016/j.breast.2012.03.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002977876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.28499", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025196507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2011.90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025928426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2011.09.058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027032477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejso.2013.09.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031855502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-014-3626-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041567037", 
          "https://doi.org/10.1245/s10434-014-3626-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b5235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062804154"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03083314"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03083314'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03083314'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03083314'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03083314'


 

This table displays all metadata directly associated to this object as RDF triples.

60 TRIPLES      16 PREDICATES      41 URIs      28 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03083314 schema:about anzsrc-for:3142
2 schema:description This is a pilot study at the National Cancer Institute (INT) of Milan evaluated the feasibility of selective axillary dissection (SAD) which preserved the lymphatic drainage of the arm. Lymph nodes draining the arm are identified following radiotracer injection and lymphoscintigraphy, a technique called axillary reverse mapping (ARM). SAD was found feasible in 75% of patients. Furthermore only 9% had BCRL after SAD compared to 33% after axillary lymph node dissection (ALND). Detailed Description To evaluate the efficacy, safety and cost reduction of SAD compared to standard ALND, we propose a prospective 2-arm randomised trial. The control arm consists of patients randomized to ALND, the study arm consists of patients randomized to SAD.
3 schema:endDate 2017-06-01T00:00:00Z
4 schema:keywords Milan
5 National Cancer Institute
6 arm
7 axillary dissection
8 axillary lymph node
9 breast cancer treatment
10 control arm
11 cost reduction
12 efficacy
13 feasibility
14 int
15 lymph node
16 lymphatic drainage
17 mapping
18 patient
19 radiotracers
20 randomised clinical trial
21 safety
22 study arm
23 schema:name SELECTIVE AXILLARY LYMPH NODE DISSECTION VS COMPLETE AXILLARY DISSECTION: A RANDOMISED CLINICAL TRIAL TO ASSESS THE PREVENTION OF LYMPHEDEMA IN BREAST CANCER TREATMENT
24 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03083314
25 schema:sdDatePublished 2019-03-07T15:27
26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
27 schema:sdPublisher N169827d06dbf41c297282feaeca8658e
28 schema:sponsor https://www.grid.ac/institutes/grid.417893.0
29 schema:startDate 2014-06-01T00:00:00Z
30 schema:subjectOf sg:pub.10.1245/s10434-014-3626-5
31 https://doi.org/10.1001/jama.2011.90
32 https://doi.org/10.1002/cncr.28499
33 https://doi.org/10.1016/j.breast.2012.03.002
34 https://doi.org/10.1016/j.ejso.2013.09.022
35 https://doi.org/10.1016/j.ijrobp.2011.09.058
36 https://doi.org/10.1136/bmj.b5235
37 schema:url https://clinicaltrials.gov/show/NCT03083314
38 sgo:license sg:explorer/license/
39 sgo:sdDataset clinical_trials
40 rdf:type schema:MedicalStudy
41 N169827d06dbf41c297282feaeca8658e schema:name Springer Nature - SN SciGraph project
42 rdf:type schema:Organization
43 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
44 rdf:type schema:DefinedTerm
45 sg:pub.10.1245/s10434-014-3626-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041567037
46 https://doi.org/10.1245/s10434-014-3626-5
47 rdf:type schema:CreativeWork
48 https://doi.org/10.1001/jama.2011.90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025928426
49 rdf:type schema:CreativeWork
50 https://doi.org/10.1002/cncr.28499 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025196507
51 rdf:type schema:CreativeWork
52 https://doi.org/10.1016/j.breast.2012.03.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002977876
53 rdf:type schema:CreativeWork
54 https://doi.org/10.1016/j.ejso.2013.09.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031855502
55 rdf:type schema:CreativeWork
56 https://doi.org/10.1016/j.ijrobp.2011.09.058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027032477
57 rdf:type schema:CreativeWork
58 https://doi.org/10.1136/bmj.b5235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062804154
59 rdf:type schema:CreativeWork
60 https://www.grid.ac/institutes/grid.417893.0 schema:Organization
 




Preview window. Press ESC to close (or click here)


...